title: [Results of the treatment of myeloblastic crisis in myelocytic leukemia using the HAR program].
authors.forename: H
authors.initials: H
authors.lastname: Zdziechowska
authors.forename: E
authors.initials: E
authors.lastname: Niemierko
authors.forename: M
authors.initials: M
authors.lastname: Takiel
authors.forename: L
authors.initials: L
authors.lastname: Konopka
authors.forename: S
authors.initials: S
authors.lastname: Pawelski
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001752:Blast Crisis / Q000188:drug therapy*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology
chemical_list: D003561:Cytarabine; D006918:Hydroxyurea; D003630:Daunorubicin
vernacular_title: Wyniki leczenia zaostrzeń mieloblastycznych przewlekłej białaczki szpikowej według programu HAR.